Medpace Holdings, Inc. (MEDP)
Sector: Industrials
Industry: Services-Commercial Physical & Biological Research
Country: United States
Exchange: NASDAQ
Market cap: $17.17B
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Latest financial period: June 30, 2026
Filed with the SEC: July 23, 2026
Estimated earnings date: October 28, 2026
Profit #23 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 98.2% | 96.5% | 96.3% | 96.1% |
Growth #300 of 1484 companies
Payout #553 of 1484 companies
Safety #685 of 1484 companies
Price #893 of 1484 companies
